Diseases associated with oxidative stress, such as Alzheimer’s and Parkinson’s, often exhibit impaired Nrf2 (nuclear factor erythroid 2-related factor [16]) signaling, which facilitates cancer cell survival and resistance to chemotherapy [17,18,19]. Here, NFE2L2 is linked to cancer.